Condition

Non-Small Cell Lung Cancer

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 903 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials903
Recruiting177
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

60 shown
DK222 Study at HopkinsNCT07140315 · 2027-01-31
RECRUITING
A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung CancerNCT07603856 · 2026-12-12
RECRUITING
Evaluation of XYA02 in Patients With Advanced Solid TumorsNCT07670312 · 2026-09-17
RECRUITING
A Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) With Acquired Resistance to Immunotherapy and High Yes-associated Protein (YAP) ExpressionNCT07412262 · 2026-08-28
RECRUITING
TCR1188-ABC Cells in KRAS-mutated CancersNCT07594067 · 2026-08-01
RECRUITING
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung CancerNCT07659782 · 2026-07-22
RECRUITING
Ph1/2 Trial Of Navlimetostat With Pumitamig In MTAP-Deficient Advanced Non-Small Cell Lung CancerNCT07579221 · 2026-07-16
RECRUITING
A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)NCT07622186 · 2026-07-15
RECRUITING
A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung CancerNCT07538804 · 2026-07-10
RECRUITING
Clinical Trial Evaluating the Safety and Efficacy of Chemoimmunotherapy Plus Short Course of Mek Inhibitor in First Line of Treatment of Metastatic Non Squamous Non Small Cell Lung Adenocarcinoma With PDL1 < 50 %.NCT05937906 · 2026-07-07
RECRUITING
A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Non-Small Cell Lung CancerNCT07623356 · 2026-07-07
RECRUITING
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLCNCT07489066 · 2026-06-30
RECRUITING
SIB Accelerated Hyperfractionated RT for High-Proliferation NSCLCNCT07823855 · 2026-06-16
RECRUITING
Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing ChemoradiationNCT06634056 · 2026-06-15
RECRUITING
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS MutationsNCT07629960 · 2026-06-04
RECRUITING
A Study of MET Concordance and Gene Profiling in 1L NSCLC (Genomet)NCT07613424 · 2026-06-02
RECRUITING
Boosting Osimertinib Blood Brain Barrier PenetrationNCT07485452 · 2026-06-01
RECRUITING
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung CancerNCT07619339 · 2026-05-27
RECRUITING
A Phase 1 Study of IM-1617 in Participants With Advanced CancerNCT07578571 · 2026-05-21
RECRUITING
A Study of Ivonescimab in People With Non-Small Cell Lung CancerNCT07594522 · 2026-05-12
RECRUITING
IMP3-saRNA Vaccine in Advanced NSCLCNCT07561723 · 2026-04-30
RECRUITING
A Phase II Clinical Trial of SHR-1826 for Non-Small Cell Lung CancerNCT07489716 · 2026-04-29
RECRUITING
A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung CancerNCT07439094 · 2026-04-16
RECRUITING
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung CancerNCT07535463 · 2026-04-10
RECRUITING
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung CancerNCT07535437 · 2026-04-09
RECRUITING
RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC)NCT07416474 · 2026-04-03
RECRUITING
EXERCISE AND THE IMMUNE RESPONSE IN LUNG CANCERNCT07267000 · 2026-04-01
RECRUITING
Phase II Study of Sacituzumab Tirumotecan in Combination With Osimertinib for Neoadjuvant Treatment in Patients With Resectable Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung CancerNCT07329322 · 2026-03-30
RECRUITING
Pivotal Study to Evaluate YL202 Versus Docetaxel in Patients With Locally Advanced or Metastatic EGFR Sensitive Mutation Non-Squamous Non-Small Cell Lung CancerNCT07416994 · 2026-03-18
RECRUITING
Cadherin 3(CDH3)-Targeted PET in Lung Malignant TumorsNCT07487883 · 2026-03-18
RECRUITING
Dual-Target CAR-NK Cells Targeting MSLN, EGFR, or HER2 in Advanced NSCLCNCT07641023 · 2026-03-02
RECRUITING
CHOICE:Decision Factor of EGFR-TKI in Chinese IV NSCLCNCT07413757 · 2026-03-02
RECRUITING
Singing Training vs Usual Care 6-18 Months After Surgical Resection for Non-small Cell Lung Cancer (NSCLC)NCT07460999 · 2026-03-01
RECRUITING
Progel Platinum for Air Leak Reduction After VATS Lobectomy for NSCLCNCT07479277 · 2026-02-27
RECRUITING
A Phase II Trial of LM103 for Adjuvant Treatment in Patients With Non-small Cell Lung CancerNCT07444437 · 2026-02-26
RECRUITING
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung CancerNCT07428044 · 2026-02-13
RECRUITING
Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLCNCT07467863 · 2026-02-02
RECRUITING
Iruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After LorlatinibNCT07374614 · 2026-01-31
RECRUITING
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced CancersNCT07227298 · 2026-01-30
RECRUITING
First in Human Study of SIM0610 in Solid TumorsNCT07348211 · 2026-01-19
RECRUITING
Postoperative Radiotherapy for Postoperative N2 Metastases of NSCLC in the Immunotherapy Era (Phase II)NCT07320105 · 2026-01-15
RECRUITING
Comparison of Biportal Versus Multiportal Robotic Approaches for Pulmonary Resection in NSCLCNCT07818135 · 2026-01-15
RECRUITING
A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior ChemotherapyNCT06931717 · 2026-01-12
RECRUITING
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung CancerNCT07222566 · 2026-01-06
RECRUITING
An Exploratory Study of QL1706 Plus Chemotherapy in Perioperative NSCLCNCT07452003 · 2026-01-03
RECRUITING
Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint InhibitorsNCT07161310 · 2026-01-02
RECRUITING
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid TumorsNCT07361562 · 2025-12-30
RECRUITING
Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid TumorsNCT07586826 · 2025-12-22
RECRUITING
Study to Assess the Effect of OCT-598 in Patients With Advanced Solid TumorsNCT07358806 · 2025-12-18
RECRUITING
Station 4L Lymph Node Dissection Versus No Dissection in Clinical Stage I Solid Nodule-Type Invasive NSCLCNCT07801430 · 2025-12-15
RECRUITING
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung CancerNCT07155187 · 2025-12-10
RECRUITING
A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical SurgeryNCT07182682 · 2025-12-01
RECRUITING
Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLCNCT07239661 · 2025-11-30
RECRUITING
FL-261 Imaging for Cancer Diagnosis and StagingNCT07510321 · 2025-11-27
RECRUITING
A Phase Ⅰ/Ⅱa Clinical Study of GEN-725 in Combination With DositinibNCT07362940 · 2025-11-27
RECRUITING
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid TumorsNCT07261631 · 2025-11-24
RECRUITING
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid TumorsNCT07300150 · 2025-11-21
RECRUITING
Observational Multicenter Study in Patients Receiving Chemotherapy and Amivantamab for Metastatic Non-small Cell Lung CancerNCT07563205 · 2025-11-19
RECRUITING
A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung CancerNCT07133425 · 2025-11-06
RECRUITING
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)NCT07100080 · 2025-11-05
RECRUITING

Trial status mix

COMPLETED351
RECRUITING177
TERMINATED103
UNKNOWN89
NOT_YET_RECRUITING72
ACTIVE_NOT_RECRUITING69
WITHDRAWN28
ENROLLING_BY_INVITATION5
SUSPENDED3
AVAILABLE2
NO_LONGER_AVAILABLE2
APPROVED_FOR_MARKETING1
TEMPORARILY_NOT_AVAILABLE1

Phase mix

PHASE2382
PHASE1252
PHASE3146
NA78
PHASE49
EARLY_PHASE16
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.